Cargando…

Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review

Inflammatory bowel disease (IBD) is a chronic, complex relapsing disorder characterised by immune dysregulation, gut microbiota alteration, and disturbed intestinal permeability. The diagnosis and the management of IBD are challenging due to the recurrent nature and complex evolution of the disease....

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldars-García, Laila, Gisbert, Javier P., Chaparro, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625096/ https://www.ncbi.nlm.nih.gov/pubmed/34832973 http://dx.doi.org/10.3390/ph14111190

Ejemplares similares

Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
por: Aldars-García, Laila, et al.
Publicado: (2021)

The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
por: Aldars-García, Laila, et al.
Publicado: (2021)

Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
por: Baldan-Martin, Montse, et al.
Publicado: (2023)

Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis
por: Guberna, Laura, et al.
Publicado: (2021)

Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
por: Gisbert, Javier P., et al.
Publicado: (2021)

Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease
por: Fernández-Tomé, Samuel, et al.
Publicado: (2021)

Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease
por: Bauset, Cristina, et al.
Publicado: (2021)

Microbiome, Metabolome and Inflammatory Bowel Disease
por: Ahmed, Ishfaq, et al.
Publicado: (2016)

Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease
por: Soleto, Irene, et al.
Publicado: (2023)

Comprehensive Review of Ustekinumab Utilization in Inflammatory Bowel Diseases: Insights from the ClinicalTrials.gov Registry
por: Alorfi, Nasser M, et al.
Publicado: (2023)

Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review
por: Jagt, Jasmijn Z, et al.
Publicado: (2022)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease
por: Guan, Qingdong
Publicado: (2019)

A Comprehensive Review of Inflammatory Bowel Disease Focusing on Surgical Management
por: Baik, Seung Hyuk, et al.
Publicado: (2012)

Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review
por: Salaritabar, Ali, et al.
Publicado: (2017)

Inflammatory Bowel Disease Treatment in Cancer Patients—A Comprehensive Review
por: Conceição, Daniel, et al.
Publicado: (2023)

The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU
por: Chaparro, María, et al.
Publicado: (2021)

Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease
por: Gisbert, Javier P., et al.
Publicado: (2023)

Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review
por: Gisbert, Javier P.
Publicado: (2020)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
por: Chaparro, María, et al.
Publicado: (2019)

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience
por: Barreiro‐de Acosta, Manuel, et al.
Publicado: (2021)

Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
por: Rubín de Célix, Cristina, et al.
Publicado: (2022)

Insights into the treatment of inflammatory bowel disease in pregnancy
por: Shannahan, Sarah E., et al.
Publicado: (2019)

Translational Potential of Metabolomics on Animal Models of Inflammatory Bowel Disease—A Systematic Critical Review
por: Knudsen, Lina Almind, et al.
Publicado: (2020)

Treatment of Inflammatory Bowel Disease: A Comprehensive Review
por: Cai, Zhaobei, et al.
Publicado: (2021)

Mucosal Metabolomic Signatures in Chronic Colitis: Novel Insights into the Pathophysiology of Inflammatory Bowel Disease
por: Calzadilla, Nathan, et al.
Publicado: (2023)

MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE
por: Rodríguez, C., et al.
Publicado: (2020)

A comprehensive review of vaccination in patients with inflammatory bowel diseases: An Indian perspective
por: Shah, Bhavik Bharat, et al.
Publicado: (2020)

Insights on the use of biosimilars in the treatment of inflammatory bowel disease
por: Zheng, Michael K, et al.
Publicado: (2017)

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane, Erin R, et al.
Publicado: (2017)

Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review
por: Takahashi, Kazuya, et al.
Publicado: (2021)

Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review
por: Direito, Rosa, et al.
Publicado: (2023)

Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
por: Gala, Dhir, et al.
Publicado: (2022)

Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature
por: Turse, Erica P, et al.
Publicado: (2018)

Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review
por: Gisbert, Javier P, et al.
Publicado: (2013)

Insights into the role of cannabis in the management of inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Flavonoids in Inflammatory Bowel Disease: A Review
por: Vezza, Teresa, et al.
Publicado: (2016)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Insight into the Relationship between Oral Microbiota and the Inflammatory Bowel Disease
por: Han, Yimin, et al.
Publicado: (2022)

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
por: Li, Mengfan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fel9g4tmnoa87i38oibud2o4vk